☰

Edith Zemanick, MD - Publications

Affiliations: 
Children's Hospital Colorado, Denver, Colorado, United States 
Tree Info Similar researchers PubMed Report error

48 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Wagner BD, Zemanick ET, Sagel SD, Robertson CE, Stevens MJ, Mayer-Hamblett N, Retsch-Bogart G, Ramsey BW, Harris JK. Limited effects of azithromycin on the oropharyngeal microbiome in children with CF and early pseudomonas infection. Bmc Microbiology. 23: 312. PMID 37891457 DOI: 10.1186/s12866-023-03073-8  0.316
2023 Sanders DB, Bartz TM, Zemanick ET, Hoppe JE, Hinckley Stukovsky KD, Cogen JD, Bendy L, McNamara S, Enright E, Kime NA, Kronmal RA, Edwards TC, Morgan WJ, Rosenfeld M. A Pilot Randomized Trial of Pediatric Cystic Fibrosis Pulmonary Exacerbations Treatment Strategies. Annals of the American Thoracic Society. PMID 37683122 DOI: 10.1513/AnnalsATS.202303-245OC  0.347
2023 Harris JK, Wagner BD, Robertson CE, Stevens MJ, Lingard C, Borowitz D, Leung DH, Heltshe SL, Ramsey BW, Zemanick ET. Upper airway microbiota development in infants with cystic fibrosis diagnosed by newborn screen. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 37137746 DOI: 10.1016/j.jcf.2023.04.017  0.304
2023 Jordan KD, Zemanick ET, Taylor-Cousar JL, Hoppe JE. Managing cystic fibrosis in children aged 6-11yrs: a critical review of elexacaftor/tezacaftor/ivacaftor combination therapy. Expert Review of Respiratory Medicine. 17: 97-108. PMID 36803356 DOI: 10.1080/17476348.2023.2179989  0.36
2023 Shumyatsky G, Burrell A, Chaney H, Sami I, Koumbourlis AC, Freishtat RJ, Crandall KA, Zemanick ET, Hahn A. Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis. Frontiers in Medicine. 9: 1082125. PMID 36698799 DOI: 10.3389/fmed.2022.1082125  0.341
2022 Inam Z, Felton E, Burrell A, Chaney H, Sami I, Koumbourlis AC, Freishtat RJ, Zemanick ET, Crandall KA, Hahn A. Impact of Antibiotics on the Lung Microbiome and Lung Function in Children With Cystic Fibrosis 1 Year After Hospitalization for an Initial Pulmonary Exacerbation. Open Forum Infectious Diseases. 9: ofac466. PMID 36168550 DOI: 10.1093/ofid/ofac466  0.349
2021 Poore TS, Meier M, Towler E, Martiniano SL, Brinton JT, DeBoer EM, Sagel SD, Wagner BD, Zemanick ET. Clinical characteristics of people with cystic fibrosis and frequent fungal infection. Pediatric Pulmonology. 57: 152-161. PMID 34687280 DOI: 10.1002/ppul.25741  0.383
2021 Bozzella MJ, Chaney H, Sami I, Koumbourlis A, Bost JE, Zemanick ET, Freishtat RJ, Crandall KA, Hahn A. Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Airway Microbiome Diversity and Pulmonary Function. The Pediatric Infectious Disease Journal. PMID 34269323 DOI: 10.1097/INF.0000000000003211  0.33
2021 Poore TS, Taylor-Cousar JL, Zemanick ET. Cardiovascular complications in cystic fibrosis: A review of the literature. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 34140249 DOI: 10.1016/j.jcf.2021.04.016  0.343
2021 Poore TS, Hong G, Zemanick ET. Fungal Infection and Inflammation in Cystic Fibrosis. Pathogens (Basel, Switzerland). 10. PMID 34069863 DOI: 10.3390/pathogens10050618  0.334
2021 Lenhart-Pendergrass PM, Anthony M, Sariyska S, Andrews A, Scavezze H, Towler E, Martiniano SL, Hoppe JE, Zemanick ET. Detection of bacterial pathogens using home oropharyngeal swab collection in children with cystic fibrosis. Pediatric Pulmonology. PMID 33847465 DOI: 10.1002/ppul.25421  0.368
2020 Khalaf RT, Furuta GT, Wagner BD, Robertson CE, Andrews R, Stevens MJ, Fillon SA, Zemanick ET, Harris JK. Influence of Acid Blockade on the Aerodigestive Tract Microbiome in Children With Cystic Fibrosis. Journal of Pediatric Gastroenterology and Nutrition. PMID 33394582 DOI: 10.1097/MPG.0000000000003010  0.325
2020 Hoppe JE, Hinds DM, Colborg A, Wagner BD, Morgan WJ, Rosenfeld M, Zemanick ET, Sanders DB. Oral antibiotic prescribing patterns for treatment of pulmonary exacerbations in two large pediatric CF centers. Pediatric Pulmonology. PMID 32970375 DOI: 10.1002/ppul.25092  0.4
2020 Hahn A, Burrell A, Ansusinha E, Peng D, Chaney H, Sami I, Perez GF, Koumbourlis AC, McCarter R, Freishtat RJ, Crandall KA, Zemanick ET. Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation. Heliyon. 6: e04104. PMID 32514485 DOI: 10.1016/J.Heliyon.2020.E04104  0.344
2019 Martiniano SL, Esther CR, Haworth CS, Kasperbauer SH, Zemanick ET, Caverly LJ. Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis. Pediatric Pulmonology. PMID 31821718 DOI: 10.1002/ppul.24604  0.341
2019 Zemanick E, Burgel PR, Taccetti G, Holmes A, Ratjen F, Byrnes CA, Waters VJ, Bell SC, VanDevanter DR, Stuart Elborn J, Flume PA. Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 31680041 DOI: 10.1016/J.Jcf.2019.10.006  0.371
2019 Harris JK, Wagner BD, Zemanick ET, Robertson CE, Stevens MJ, Heltshe SL, Rowe SM, Sagel SD. Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation. Annals of the American Thoracic Society. PMID 31604026 DOI: 10.1513/Annalsats.201907-493Oc  0.369
2019 Theprungsirikul J, Skopelja-Gardner S, Meagher RE, Clancy JP, Zemanick ET, Ashare A, Rigby WFC. Dissociation of systemic and mucosal autoimmunity in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 31262645 DOI: 10.1016/J.Jcf.2019.06.006  0.338
2019 Martiniano SL, Daines CL, Dellon EP, Esther CR, Muhlebach MS, Ong T, Rabinowitz EC, Toprak D, Zemanick ET. Highlights from the 2018 North American cystic fibrosis conference. Pediatric Pulmonology. PMID 31091021 DOI: 10.1002/Ppul.24356  0.305
2019 Hahn A, Fanous H, Jensen C, Chaney H, Sami I, Perez GF, Koumbourlis AC, Louie S, Bost JE, van den Anker JN, Freishtat RJ, Zemanick ET, Crandall KA. Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis. Scientific Reports. 9: 2534. PMID 30796252 DOI: 10.1038/S41598-019-38984-Y  0.319
2018 DeBoer EM, Wagner BD, Popler J, Harris JK, Zemanick ET, Accurso FJ, Sagel SD, Deterding RR. Novel Application of Aptamer Proteomic Analysis in Cystic Fibrosis Bronchoalveolar Lavage Fluid. Proteomics. Clinical Applications. e1800085. PMID 30431231 DOI: 10.1002/Prca.201800085  0.366
2018 Hoppe JE, Wagner BD, Accurso FJ, Zemanick ET, Sagel SD. Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 29921503 DOI: 10.1016/J.Jcf.2018.05.015  0.376
2018 Martiniano SL, Toprak D, Ong T, Zemanick ET, Daines CL, Muhlebach MS, Esther CR, Dellon EP. Highlights from the 2017 North American Cystic Fibrosis Conference. Pediatric Pulmonology. PMID 29660839 DOI: 10.1002/Ppul.24000  0.347
2017 Hoppe JE, Wagner BD, Sagel SD, Accurso FJ, Zemanick ET. Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis. Bmc Pulmonary Medicine. 17: 188. PMID 29228933 DOI: 10.1186/S12890-017-0546-8  0.306
2017 Zemanick ET, Wagner BD, Robertson CE, Ahrens RC, Chmiel JF, Clancy JP, Gibson RL, Harris WT, Kurland G, Laguna TA, McColley SA, McCoy K, Retsch-Bogart G, Sobush KT, Zeitlin PL, et al. Airway microbiota across age and disease spectrum in cystic fibrosis. The European Respiratory Journal. 50. PMID 29146601 DOI: 10.1183/13993003.00832-2017  0.395
2017 Zemanick ET, Daines CL, Dellon EP, Esther CR, Kinghorn B, Ong T, Muhlebach MS. Highlights from the 2016 North American Cystic Fibrosis Conference. Pediatric Pulmonology. PMID 28696526 DOI: 10.1002/Ppul.23707  0.338
2017 Williamson KM, Wagner BD, Robertson CE, Johnson EJ, Zemanick ET, Harris JK. Impact of enzymatic digestion on bacterial community composition in CF airway samples. Peerj. 5: e3362. PMID 28584706 DOI: 10.7717/Peerj.3362  0.308
2017 Hoppe JE, Zemanick ET. Lessons from the lower airway microbiome in early CF. Thorax. PMID 28450530 DOI: 10.1136/thoraxjnl-2017-210060  0.354
2016 Laguna TA, Wagner BD, Williams CB, Stevens MJ, Robertson CE, Welchlin CW, Moen CE, Zemanick ET, Harris JK. Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis. Plos One. 11: e0167649. PMID 27930727 DOI: 10.1371/Journal.Pone.0167649  0.318
2016 Zemanick ET, Hoffman LR. Cystic Fibrosis: Microbiology and Host Response. Pediatric Clinics of North America. 63: 617-36. PMID 27469179 DOI: 10.1016/j.pcl.2016.04.003  0.381
2016 Martiniano SL, Sagel SD, Zemanick ET. Cystic fibrosis: a model system for precision medicine. Current Opinion in Pediatrics. PMID 27031658 DOI: 10.1097/MOP.0000000000000351  0.362
2016 Zemanick ET, Wainwright C. Alterations of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis. Cystic Fibrosis Transmembrane Conductance Regulator and Antibiotic Effects. American Journal of Respiratory and Critical Care Medicine. 193: 473-4. PMID 26930426 DOI: 10.1164/rccm.201511-2200ED  0.319
2016 Johnson EJ, Zemanick ET, Accurso FJ, Wagner BD, Robertson CE, Harris JK. Molecular Identification of Staphylococcus aureus in Airway Samples from Children with Cystic Fibrosis. Plos One. 11: e0147643. PMID 26808658 DOI: 10.1371/Journal.Pone.0147643  0.316
2016 Hoppe JE, Harris JK, Zemanick ET. Assessing the Airway Microbiota in Cystic Fibrosis Clinical Microbiology Newsletter. 38: 179-184. DOI: 10.1016/j.clinmicnews.2016.10.004  0.335
2015 Ma DC, Yoon AJ, Faull KF, Desharnais R, Zemanick ET, Porter E. Cholesteryl esters are elevated in the lipid fraction of bronchoalveolar lavage fluid collected from pediatric cystic fibrosis patients. Plos One. 10: e0125326. PMID 25919295 DOI: 10.1371/Journal.Pone.0125326  0.349
2015 Flass T, Tong S, Frank DN, Wagner BD, Robertson CE, Kotter CV, Sokol RJ, Zemanick E, Accurso F, Hoffenberg EJ, Narkewicz MR. Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis. Plos One. 10: e0116967. PMID 25658710 DOI: 10.1371/Journal.Pone.0116967  0.305
2015 Hoppe JE, Towler E, Wagner BD, Accurso FJ, Sagel SD, Zemanick ET. Sputum induction improves detection of pathogens in children with cystic fibrosis. Pediatric Pulmonology. 50: 638-46. PMID 25565628 DOI: 10.1002/Ppul.23150  0.361
2015 Zemanick ET, Wagner BD, Robertson CE, Stevens MJ, Szefler SJ, Accurso FJ, Sagel SD, Harris JK. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods. Annals of the American Thoracic Society. 12: 221-9. PMID 25474078 DOI: 10.1513/Annalsats.201407-310Oc  0.329
2015 Zemanick ET, Emerson J, Thompson V, McNamara S, Morgan W, Gibson RL, Rosenfeld M. Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis. Pediatric Pulmonology. 50: 42-8. PMID 24644274 DOI: 10.1002/Ppul.23036  0.32
2014 Martiniano SL, Hoppe JE, Sagel SD, Zemanick ET. Advances in the diagnosis and treatment of cystic fibrosis. Advances in Pediatrics. 61: 225-43. PMID 25037130 DOI: 10.1016/j.yapd.2014.03.002  0.366
2014 Zemanick ET, Accurso FJ. Cystic fibrosis transmembrane conductance regulator and pseudomonas. American Journal of Respiratory and Critical Care Medicine. 189: 763-5. PMID 24684355 DOI: 10.1164/Rccm.201402-0209Ed  0.334
2013 Zemanick ET, Harris JK, Wagner BD, Robertson CE, Sagel SD, Stevens MJ, Accurso FJ, Laguna TA. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations. Plos One. 8: e62917. PMID 23646159 DOI: 10.1371/Journal.Pone.0062917  0.388
2012 Sagel SD, Wagner BD, Anthony MM, Emmett P, Zemanick ET. Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 186: 857-65. PMID 22904182 DOI: 10.1164/rccm.201203-0507OC  0.336
2011 Zemanick ET, Sagel SD, Harris JK. The airway microbiome in cystic fibrosis and implications for treatment. Current Opinion in Pediatrics. 23: 319-24. PMID 21494150 DOI: 10.1097/MOP.0b013e32834604f2  0.408
2010 Zemanick ET, Wagner BD, Sagel SD, Stevens MJ, Accurso FJ, Harris JK. Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens. Plos One. 5: e15101. PMID 21152087 DOI: 10.1371/Journal.Pone.0015101  0.385
2010 Zemanick ET, Wagner BD, Harris JK, Wagener JS, Accurso FJ, Sagel SD. Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures. Pediatric Pulmonology. 45: 569-77. PMID 20503282 DOI: 10.1002/Ppul.21221  0.376
2010 Zemanick ET, Harris JK, Conway S, Konstan MW, Marshall B, Quittner AL, Retsch-Bogart G, Saiman L, Accurso FJ. Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 9: 1-16. PMID 19833563 DOI: 10.1016/J.Jcf.2009.09.003  0.376
2007 Harris JK, De Groote MA, Sagel SD, Zemanick ET, Kapsner R, Penvari C, Kaess H, Deterding RR, Accurso FJ, Pace NR. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proceedings of the National Academy of Sciences of the United States of America. 104: 20529-33. PMID 18077362 DOI: 10.1073/Pnas.0709804104  0.374
Show low-probability matches.